Jazz Pharmaceuticals (JAZZ) Tops Q4 EPS by 25c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 231.67 +1.93 (0.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $229.74 | 52 Week High | $160.00 | |||
| Open | $233.23 | 52 Week Low | $95.80 | |||
| Day High | $233.50 | P/E | 43.06 | |||
| Day Low | $228.45 | EPS | $5.38 | |||
| Volume | 274,464 | |||||
